» Articles » PMID: 39337637

Pathogenesis of Inflammation in Skin Disease: From Molecular Mechanisms to Pathology

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Sep 28
PMID 39337637
Authors
Affiliations
Soon will be listed here.
Abstract

Many skin diseases begin with inflammatory changes on a molecular level. To develop a more thorough understanding of skin pathology and to identify new targets for therapeutic advancements, molecular mechanisms of inflammation in the context of skin disease should be studied. Current research efforts to better understand skin disease have focused on examining the role of molecular processes at several stages of the inflammatory response such as the dysregulation of innate immunity sensors, disruption of both transcriptional and post-transcriptional regulation, and crosstalk between immune and neuronal processes (neuro-immune crosstalk). This review seeks to summarize recent developments in our understanding of inflammatory processes in skin disease and to highlight opportunities for therapeutic advancements. With a focus on publications within the past 5 years (2019-2024), the databases PubMed and EBSCOhost were used to search for peer-reviewed papers regarding inflammatory molecular mechanisms and skin disease. Several themes of research interest regarding inflammatory processes in skin disease were determined through extensive review and were included based on their relative representation in current research and their focus on therapeutic potential. Several skin diseases such as psoriasis, atopic dermatitis, hidradenitis suppurativa, and scleroderma were described in the paper to demonstrate the widespread influence of inflammation in skin disease.

References
1.
Roger A, Reynders A, Hoeffel G, Ugolini S . Neuroimmune crosstalk in the skin: a delicate balance governing inflammatory processes. Curr Opin Immunol. 2022; 77:102212. DOI: 10.1016/j.coi.2022.102212. View

2.
Nakao M, Sugaya M, Fujita H, Miyagaki T, Morimura S, Shibata S . TLR2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation through Decrease in Regulatory T Cells and Impaired IL-10 Production. Int J Mol Sci. 2020; 21(22). PMC: 7696365. DOI: 10.3390/ijms21228560. View

3.
Fragoso N, Masson R, Gillenwater T, Shi V, Hsiao J . Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies. Dermatol Ther (Heidelb). 2023; 13(8):1661-1697. PMC: 10366071. DOI: 10.1007/s13555-023-00956-6. View

4.
Dec M, Arasiewicz H . Aryl hydrocarbon receptor role in chronic inflammatory skin diseases: a narrative review. Postepy Dermatol Alergol. 2024; 41(1):9-19. PMC: 10962376. DOI: 10.5114/ada.2023.135617. View

5.
Abd-Elmawla M, Hassan M, Elsabagh Y, Alnaggar A, Senousy M . Deregulation of long noncoding RNAs ANCR, TINCR, HOTTIP and SPRY4-IT1 in plasma of systemic sclerosis patients: SPRY4-IT1 as a novel biomarker of scleroderma and its subtypes. Cytokine. 2020; 133:155124. DOI: 10.1016/j.cyto.2020.155124. View